NASHVILLE, Tenn., March 17/PRNewswire/ -- Brad Tice, Pharm.D., chief clinical officer of PharmMD, will be named a fellow of the American Pharmacists Association (APhA) at its upcoming annual meeting, scheduled for March 14-17 in San Diego, Calif.
Among his many career accomplishments, Dr. Tice helped make medication therapy management (MTM) what it is today. MTM refers to the process of preventing drug error, overuse and abuse by ensuring that individual patients receive the most appropriate medications possible. Dr. Tice was a member of the team that wrote the accepted clinical definition of MTM approved by 11 organizations including the APhA. He also participated on the advisory panel that developed the MTM model jointly issued by APhA and NACDS. As evidence of the increasing value and importance of MTM, the Centers for Medicare and Medicaid Services (CMS) began in 2006 requiring each sponsor of its Part D drug benefits to incorporate an MTM program into their plan's benefit structure. CMS leadership has referred to MTM as the "cornerstone" of the Part D Medicare benefit.
Dr. Tice currently serves as chief clinical officer for PharmMD, an MTM provider that works with employers, government plans and other payers to help ensure that beneficiaries are receiving the most appropriate medications by improving coordination and communication among physicians, pharmacists, payers and patients. The company analyzes medical and pharmaceutical utilization records to prevent harmful drug interactions and costly duplications. After only one quarter of providing MTM services to approximately 3,000 covered lives at a large, self-insured employer, PharmMD reported $3 saved for ever $1 spent on its services.
"As our company's clinical leader, Dr. Tice's services have likely saved several lives and improved many more," said Bo Bartholomew, founder and CEO of PharmMD. "He is a pioneer in his industry and a critical member of our executive team."
The APhA Fellow Award was established in 1987 to honor members who have demonstrated progressive, exemplary service and achievements in their professional area through service to APhA academies and other national, state, and local professional organizations. Recipients must have at least 10 years professional pharmacy experience.
Dr. Tice is among only 17 individuals to receive the APhA Fellow Award this year, which is given to a maximum of 20 individuals each year. As a member of the APhA Academy of Pharmacy Practice and Management, Dr. Tice has held numerous leadership positions including member-at-large of the executive committee and chair of the clinical/pharmacotherapeutic section. He sat on the advisory board of the Journal of the American Pharmacists Association for several years and also served as speaker of the house, vice-speaker and member of the board of trustees of the Iowa Pharmacists Association. He has also been actively involved in the Pharmacy Quality Alliance (PQA) and currently serves as the co-chair of its Quality Metrics Workgroup.
"Medication error, overuse and abuse are pressing issues in today's healthcare environment, and, if applied properly, the principles of MTM can go a long way to preventing these negative events," said Dr. Tice. "It is exciting to operate on the cutting edge of such an important healthcare trend."
Dr. Tice began his pharmacy career focusing on the delivery of patient care services for Osco Drug, first as a pharmacist in Kansas City, Kan., and later as a pharmacy manager for Osco Drug in Davenport, Iowa. He later became an assistant and associate professor at the Drake University College of Pharmacy and Health Sciences and Director of the Osco Drug/Drake University Community Care Laboratory. Dr. Tice earned his bachelor's of science and doctorate in pharmacy from the University of Kansas.
Dr. Tice was awarded the Iowa Pharmacy Association Young Pharmacist of the Year in 2001 and the 2005 Alfred B. Prescott/GlaxoSmithKline Leadership Award.
PharmMD is an MTM provider based in Brentwood, Tenn., that works with employers and payers to help ensure that beneficiaries are receiving the most appropriate medications. Founded in 2006, PharmMD improves coordination and communication among physicians, pharmacists, payers and patients by analyzing pharmacy and medical claims information and clinical decision making. Because PharmMD focuses exclusively on MTM, the company is able to analyze both aggregate and patient-specific data to identify trends and conflicts to positively impact patient health and contain costs. More information at: http://www.pharmmd.com .
About the American Pharmacists Association (APhA)
The American Pharmacists Association is dedicated to improving medication use and advancing patient care. APhA's awards and recognition program is American Pharmacy's most comprehensive recognition program. Founded in 1852 as the American Pharmaceutical Association, APhA is the first-established and largest professional association of pharmacists in the United States. Its more than 60,000 members include pharmacists, scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession.
Copyright©2008 PR Newswire.
All rights reserved